logo

Epizyme, Inc. (EPZM)



Trade EPZM now with
  Date
  Headline
6/15/2018 5:37:30 AM Epizyme Reports Positive Updated Interim Data From Phase 2 Study Of Tazemetostat
5/18/2018 7:29:18 AM Wedbush Is Cutting Epizyme, Inc. (EPZM) FY19 Estimate To -1.67 From -1.53
5/18/2018 7:28:55 AM Wedbush Is Lowering Epizyme, Inc. (EPZM) Q4 19 Estimate To -0.43 From -0.36
5/18/2018 7:28:11 AM Wedbush Is Lowering Epizyme, Inc. (EPZM) Q3 19 Estimate To -0.42 From -0.39
5/18/2018 7:27:48 AM Wedbush Is Cutting Epizyme, Inc. (EPZM) Q2 19 Estimate To -0.41 From -0.39
5/18/2018 7:27:41 AM Wedbush Is Cutting Epizyme, Inc. (EPZM) Q1 19 Estimate To -0.41 From -0.39
5/18/2018 7:27:26 AM Wedbush Is Cutting Epizyme, Inc. (EPZM) FY18 Estimate To -1.85 From -1.79
5/18/2018 7:27:13 AM Wedbush Is Lowering Epizyme, Inc. (EPZM) Q4 18 Estimate To -0.44 From -0.39
5/8/2018 7:40:34 AM Epizyme Q1 Net Loss $34.1 Mln Or $0.49/shr Vs Loss $32.5 Mln Or $0.56/Shr Last Year
4/24/2018 9:14:14 AM Wedbush Is Increasing Epizyme, Inc. (EPZM) FY18 Estimate To -2.00 From -2.02
4/24/2018 9:13:56 AM Wedbush Is Increasing Epizyme, Inc. (EPZM) Q4 18 Estimate To -0.44 From -0.46
3/14/2018 6:36:52 AM Wedbush Is Raising Epizyme, Inc. (EPZM) FY18 Estimate To -2.02 From -2.15
3/14/2018 6:36:24 AM Wedbush Is Increasing Epizyme, Inc. (EPZM) Q4 18 Estimate To -0.46 From -0.47
3/14/2018 6:36:09 AM Wedbush Is Increasing Epizyme, Inc. (EPZM) Q3 18 Estimate To -0.51 From -0.55
3/14/2018 6:35:56 AM Wedbush Is Increasing Epizyme, Inc. (EPZM) Q2 18 Estimate To -0.53 From -0.57
3/14/2018 6:35:43 AM Wedbush Is Raising Epizyme, Inc. (EPZM) Q1 18 Estimate To -0.52 From -0.56
3/13/2018 7:38:23 AM Epizyme Q4 Net Loss $36.2 Mln Or $0.52/Shr Vs $35.0 Mln Or $0.60/Shr Last Year